MetLife Investment Management’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $377K | Hold |
40,598
| – | – | ﹤0.01% | 1813 |
|
|
2025
Q1 | $396K | Buy |
40,598
+2,939
| +8% | +$28.7K | ﹤0.01% | 1834 |
|
|
2024
Q4 | $456K | Buy |
37,659
+2,525
| +7% | +$30.6K | ﹤0.01% | 1852 |
|
|
2024
Q3 | $385K | Buy |
35,134
+6,216
| +21% | +$68.1K | ﹤0.01% | 1921 |
|
|
2024
Q2 | $260K | Buy |
28,918
+2,273
| +9% | +$20.5K | ﹤0.01% | 2082 |
|
|
2024
Q1 | $218K | Hold |
26,645
| – | – | ﹤0.01% | 2160 |
|
|
2023
Q4 | $225K | Buy |
26,645
+5,140
| +24% | +$43.3K | ﹤0.01% | 2176 |
|
|
2023
Q3 | $368K | Hold |
21,505
| – | – | ﹤0.01% | 1814 |
|
|
2023
Q2 | $499K | Sell |
21,505
-3,069
| -12% | -$71.3K | ﹤0.01% | 1691 |
|
|
2023
Q1 | $434K | Buy |
24,574
+2,948
| +14% | +$52.1K | ﹤0.01% | 1729 |
|
|
2022
Q4 | $588K | Hold |
21,626
| – | – | ﹤0.01% | 1533 |
|
|
2022
Q3 | $373K | Buy |
21,626
+6,417
| +42% | +$111K | ﹤0.01% | 1850 |
|
|
2022
Q2 | $266K | Hold |
15,209
| – | – | ﹤0.01% | 2110 |
|
|
2022
Q1 | $258K | Buy |
15,209
+5,344
| +54% | +$90.7K | ﹤0.01% | 2190 |
|
|
2021
Q4 | $267K | Hold |
9,865
| – | – | ﹤0.01% | 1876 |
|
|
2021
Q3 | $292K | Hold |
9,865
| – | – | ﹤0.01% | 1835 |
|
|
2021
Q2 | $379K | Hold |
9,865
| – | – | ﹤0.01% | 1740 |
|
|
2021
Q1 | $301K | Hold |
9,865
| – | – | ﹤0.01% | 1810 |
|
|
2020
Q4 | $376K | Hold |
9,865
| – | – | ﹤0.01% | 1620 |
|
|
2020
Q3 | $227K | Hold |
9,865
| – | – | ﹤0.01% | 1794 |
|
|
2020
Q2 | $245K | Buy |
+9,865
| New | +$245K | ﹤0.01% | 1781 |
|